Comprehensive blood conservation program in a new congenital cardiac surgical program allows bloodless surgery for the Jehovah Witness and a reduction for all patients
- PMID: 28985692
- DOI: 10.1177/0267659117733810
Comprehensive blood conservation program in a new congenital cardiac surgical program allows bloodless surgery for the Jehovah Witness and a reduction for all patients
Abstract
Background: Cardiac surgery on Jehovah's Witnesses (JW) can be challenging, given the desire to avoid blood products. Establishment of a blood conservation program involving the pre-, intra- and post-operative stages for all patients may lead to a minimized need for blood transfusion in all patients.
Methods: Pre-operatively, all JW patients were treated with high dose erythropoietin 500 IU/kg twice a week. JW patients were compared to matching non-JW patients from the congenital cardiac database, two per JW to serve as control. Blood use, ventilation time, bypass time, pre-operative hematocrit, first in intensive care unit (ICU) and at discharge and 24 hour chest drainage were compared. Pre-operative huddle, operating room huddle and post-operative bedside handoff were done with the congenital cardiac surgeon, perfusionist, anesthesiologist and intensive care team in all patients for goal alignment.
Results: Five JW patients (mean weight 24.4 ± 25.0 Kg, range 6.3 - 60 Kg) were compared to 10 non-JW patients (weight 22.0 ± 22.8 Kg, range 6.2 - 67.8 Kg). There was no difference in bypass, cross-clamp, time to extubation (0.8 vs. 2.1 hours), peak inotrope score (2.0 vs. 2.3) or chest drainage. No JW patient received a blood product compared to 40% of non-JW. The pre-operative hematocrit (Hct) was statistically greater for the JW patients (46.1 ± 3.3% vs. 36.3 ± 4.7%, p<0.001) and both ICU and discharge Hct were higher for the JW (37 ± 1.8% vs 32.4 ± 8.0% and 41 ± 8.1% vs 34.8 ± 7.9%), but did not reach statistical significance. All patients had similar blood draws during the hospitalization (JW x 18 mL/admission vs non-JW 20 mL/admission).
Conclusion: The continuous application and development of blood conservation techniques across the continuum of care allowed bloodless surgery for JW and non-JW patients alike. Blood conservation is a team sport and to make significant strides requires participation and input by all care providers.
Keywords: Jehovah’s Witness; blood conservation; bloodless; congenital.
Similar articles
-
Outcomes of cardiac surgery in Jehovah's Witness patients: A review.Perfusion. 2021 Oct;36(7):661-671. doi: 10.1177/0267659120980375. Epub 2020 Dec 16. Perfusion. 2021. PMID: 33325336 Free PMC article. Review.
-
Perioperative Management of a Child with Hypoplastic Left Heart Syndrome of the Jehovah's Witness Faith Presenting for Hybrid Comprehensive Stage II Procedure.J Extra Corpor Technol. 2016 Sep;48(3):141-147. J Extra Corpor Technol. 2016. PMID: 27729708 Free PMC article.
-
Bloodless Arterial Switch Operation in a 2.7-kg Jehovah's Witness Patient.J Extra Corpor Technol. 2020 Jun;52(2):142-145. doi: 10.1182/ject-2000003. J Extra Corpor Technol. 2020. PMID: 32669741 Free PMC article.
-
Jehovah's Witnesses and cardiac surgery: a single institution's experience.Transfusion. 2014 Oct;54(10 Pt 2):2745-52. doi: 10.1111/trf.12696. Epub 2014 May 9. Transfusion. 2014. PMID: 24809815
-
Should Jehovah's Witness patients be listed for heart transplantation?Interact Cardiovasc Thorac Surg. 2012 Oct;15(4):716-9. doi: 10.1093/icvts/ivs157. Epub 2012 Jun 29. Interact Cardiovasc Thorac Surg. 2012. PMID: 22753433 Free PMC article. Review.
Cited by
-
Outcomes associated with absent blood product utilization in Jehovah's witness patients compared to the standard of care in cardiac surgery: A ten-year experience.Perfusion. 2025 May;40(4):869-876. doi: 10.1177/02676591241258072. Epub 2024 Jun 12. Perfusion. 2025. PMID: 38864565 Free PMC article.
-
Pediatric Perioperative Clinical Pharmacy Practice: Clinical Considerations and Management: An Opinion of the Pediatrics and Perioperative Care Practice and Research Networks of the American College of Clinical Pharmacy.J Pediatr Pharmacol Ther. 2022;27(6):490-505. doi: 10.5863/1551-6776-27.6.490. Epub 2022 Aug 19. J Pediatr Pharmacol Ther. 2022. PMID: 36042955 Free PMC article.
-
Outcomes of cardiac surgery in Jehovah's Witness patients: A review.Perfusion. 2021 Oct;36(7):661-671. doi: 10.1177/0267659120980375. Epub 2020 Dec 16. Perfusion. 2021. PMID: 33325336 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical